Pharma-backed TransCelerate makes progress on clinical trial efficiency
This article was originally published in Scrip
Executive Summary
TransCelerate BioPharma has taken swift action on all five objectives outlined in 2012 when the group was established by 10 big pharma companies to quickly address issues that hamper clinical trial efficiency, and the group has adopted a list of five new priorities.